Concurrent Investment Advisors’s AdvisorShares Pure US Cannabis ETF MSOS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$25.4K Buy
+5,000
New +$23.4K ﹤0.01% 2081
2026
Q1
– Sell
-75,600
Closed -$357K – 2005
2025
Q4
$357K Buy
75,600
+23,300
+45% +$104K ﹤0.01% 1299
2025
Q3
$251K Buy
52,300
+42,000
+408% +$165K ﹤0.01% 1240
2025
Q2
$24.8K Buy
10,300
+10,000
+3,333% +$24.6K ﹤0.01% 1371
2025
Q1
$783 Sell
300
-52,000
-99% -$168K ﹤0.01% 1236
2024
Q4
$199K Sell
52,300
-30,500
-37% -$165K 0.01% 997
2024
Q3
$594K Buy
82,800
+77,800
+1,556% +$553K 0.02% 586
2024
Q2
$36.6K Buy
5,000
+1,300
+35% +$11.3K ﹤0.01% 946
2024
Q1
$37K Sell
3,700
-2,400
-39% -$21K ﹤0.01% 880
2023
Q4
$42.8K Buy
+6,100
New +$40.6K ﹤0.01% 834

Other funds holding MSOS

Concurrent Investment Advisors's MSOS Position: Q2 2026 in Review

Concurrent Investment Advisors reduced its AdvisorShares Pure US Cannabis ETF (MSOS) stake by 19% in Q2 2026, selling an estimated $917K and leaving 808,824 shares worth $4.11M. The position accounts for 0.04% of the portfolio, ranked #492.

Concurrent Investment Advisors first reported a position in MSOS in Q4 2023 and has held it in 11 quarters since. 169 funds tracked by Wall St. Rank hold MSOS as of Q2 2026.

  • Concurrent Investment Advisors held 808,824 shares of AdvisorShares Pure US Cannabis ETF worth $4.11M as of Q2 2026.
  • Concurrent Investment Advisors sold 195,683 AdvisorShares Pure US Cannabis ETF shares in Q2 2026, an estimated $917K.
  • AdvisorShares Pure US Cannabis ETF made up 0.04% of Concurrent Investment Advisors's portfolio in Q2 2026, its #492 holding.
  • Concurrent Investment Advisors first reported a position in AdvisorShares Pure US Cannabis ETF in Q4 2023 and has held it in 11 quarters since.
  • 169 funds tracked by Wall St. Rank held AdvisorShares Pure US Cannabis ETF as of Q2 2026.

Based on Concurrent Investment Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.